Tyler Moyer

Tyler Moyer has a diverse work experience spanning different industries. Tyler is currently working at Voyager Therapeutics, Inc. as a Senior Scientist I, focusing on Novel Capsid Discovery. Tyler previously held positions as a Scientist II and Scientist I, working on the same area of research. Prior to joining Voyager Therapeutics, Tyler worked as a PHD Candidate and NSF Graduate Research Fellow at The Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics. In this role, they investigated molecular mechanisms controlling mammalian centriole and centrosome copy number, implemented CRISPR/Cas9 genome engineering technology, and published protocols for knocking-in mutations using CRISPR/Cas9 editing. Tyler also has experience as a Graduate Intern at AstraZeneca, where they gained industry experience. Tyler also worked as a Field Executive at Chi Phi Fraternity, where they provided leadership consultation to undergraduates and organized educational leadership programs. Additionally, Tyler worked as a Science Teacher at Pine Bluff Public Schools.

Tyler Moyer completed a Bachelor of Science degree in Cell/Cellular and Molecular Biology from Bucknell University, where they studied from 2007 to 2011. Subsequently, they attended The Johns Hopkins University School of Medicine from 2013 to 2019, but there is no available information regarding the degree or field of study they pursued during that time.